Your browser doesn't support javascript.
loading
The European Regulatory Environment of RNA-Based Vaccines.
Hinz, Thomas; Kallen, Kajo; Britten, Cedrik M; Flamion, Bruno; Granzer, Ulrich; Hoos, Axel; Huber, Christoph; Khleif, Samir; Kreiter, Sebastian; Rammensee, Hans-Georg; Sahin, Ugur; Singh-Jasuja, Harpreet; Türeci, Özlem; Kalinke, Ulrich.
Afiliação
  • Hinz T; Section for Therapeutic Vaccines, Division for Immunology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Germany. thomas.hinz@pei.de.
  • Kallen K; Kallen Consulting, Köln/Frechen, Germany.
  • Britten CM; R&D Oncology, Glaxo Smith Kline, Stevenage, UK.
  • Flamion B; URPhyM, NARILIS, University of Namur, Namur, Belgium.
  • Granzer U; Granzer, Regulatory Consulting & Services, Munich, Germany.
  • Hoos A; Glaxo Smith Kline, Collegeville, PA, USA.
  • Huber C; Association for Cancer Immunotherapy, Mainz, Germany.
  • Khleif S; GHSU Cancer Center, Augusta, GA, USA.
  • Kreiter S; Association for Cancer Immunotherapy, Mainz, Germany.
  • Rammensee HG; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
  • Sahin U; German Cancer Consortium, DKFZ Partner Site, Tübingen, Germany.
  • Singh-Jasuja H; TRON - Translational Oncology at the University Medical Center, Johannes Gutenberg University, Mainz, Germany.
  • Türeci Ö; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany.
  • Kalinke U; Research Center for Immunotherapy (FZI), Mainz, Germany.
Methods Mol Biol ; 1499: 203-222, 2017.
Article em En | MEDLINE | ID: mdl-27987152
Buscar no Google
Base de dados: MEDLINE Assunto principal: RNA Mensageiro / Vacinas Anticâncer Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: RNA Mensageiro / Vacinas Anticâncer Idioma: En Ano de publicação: 2017 Tipo de documento: Article